Here are five things to know about the company’s third-quarter results.
1. CHS posted revenues of nearly $4.4 billion for the three months ended Sept. 30. That’s down 9.6 percent from operating revenues of $4.8 billion in the same period of 2015.
2. The lower revenue was attributable, in part, to a decline in patient volume. CHS said total admissions were down 12.4 percent in the third quarter of 2016 compared to the same period of the year prior. On a same-hospital basis, admissions fell 2 percent year over year.
3. During the third quarter of 2016, CHS recorded a noncash impairment charge of $39 million. “This update to the estimated goodwill impairment charge was based on the company’s updated valuation assumptions, as well as information obtained from third-party valuation services,” said CHS.
4. The company ended the third quarter with a net loss of $79 million, compared with a $52 million profit in the same period of 2015.
5. CHS is currently exploring options with financial sponsors. On Tuesday, CHS said these discussions are in a “very preliminary stage.” The company said it is not certain these talks will result in a transaction.
More articles on healthcare finance:
HCA profit rises 38% in Q3
LifePoint gets revenue boost from acquisitions
UHS profit increases as patient volume grows: 5 things to know
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.